Mode
Text Size
Log in / Sign up
N/A N=22 Randomized Treatment

An EPIC Based BPA to Enhance Quit Line Referral and Use

Smoking Cessation

Enrolled (actual)
22
Serious AEs
Results posted
Nov 2023
Primary outcome: Primary: Provider Electronic Referrals to the Maryland Quit Line — 623; 405 referrals

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Best Practices Advisory (BPA) (Other); BPA + Enhanced Education (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Johns Hopkins University
Primary completion
May 2018

Outcome Measures

OutcomeResultp-value
PRIMARY
Provider Electronic Referrals to the Maryland Quit Line
272; 186; 284; 203
SECONDARY
Prescription of Pharmacotherapy for Smoking Cessation
SECONDARY
Patient Engagement With the Quit Line
100; 80; 80; 77; 6; 7
SECONDARY
Provider Electronic Referrals to the Maryland Quit Line
272; 186; 284; 203
SECONDARY
Patient Engagement With the Quit Line
100; 80; 80; 77; 6; 7

Summary

Smoking is the number one cause of preventable death in the United States. Given the magnitude of the problem, interventions aimed at promoting smoking cessation have the potential to make large changes in improving health outcomes. Resources to aid with smoking cessation such as telephone-based counseling are generally underutilized. The electronic medical record (EMR) in use at Johns Hopkins has limited decision support to promote referral to the Maryland Quit Line, a free smoking cessation counseling resource. The investigators propose a cluster randomized trial (Implementation-RCT hybrid design) with a waitlist control at the 22 Johns Hopkins Community Physicians (JHCP) sites, which offer primary care. The intervention will include a multi-modality intervention to promote provider use of smoking cessation resources which include an Epic-based Best Practice Advisory (BPA) that allows providers to electronically refer to the Maryland State Quit Line, educational materials, and provider visits with Quit Line representatives to review use of smoking cessation practices. Sites will be randomized to one of three arms with increasing support: 1) six-month waitlist control; 2) BPA with optional educational modules; 3) BPA with online educational modules, a quick-reference educational document, and additional visit with Quit Line representatives. The investigators hypothesize that by implementing a new Epic BPA that allows providers to easily refer to the Maryland Quit Line electronically, investigators will increase use of this resource. The investigators also hypothesize that adding additional educational materials and having Quit Line representatives perform educational outreach visits will further increase use of the Quit Line and will increase prescription of medications to assist with smoking cessation. Ultimately The investigators hope to improve patient care by increasing providers' use the Maryland Quit Line and pharmacotherapy. The investigators hope that the use of these resources will decrease smoking rates and thereby improve patient health and outcomes while improving JHCP quality metrics.

Eligibility Criteria

Inclusion Criteria

  • Johns Hopkins Community Physicians Primary Care Practices (Internal Medicine and Family Medicine)

Exclusion Criteria

  • None
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03229356). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search